Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Jorge Saucedo

Concepts (377)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Angioplasty, Balloon, Coronary
40
2020
175
4.330
 Why?
Acute Coronary Syndrome
25
2020
106
4.140
 Why?
Myocardial Infarction
30
2017
445
3.750
 Why?
Platelet Aggregation Inhibitors
31
2020
211
3.610
 Why?
Registries
42
2020
629
2.600
 Why?
Percutaneous Coronary Intervention
20
2020
328
2.480
 Why?
Coronary Artery Disease
16
2020
317
2.020
 Why?
Stents
21
2020
372
1.950
 Why?
Ticlopidine
16
2016
72
1.630
 Why?
Risk Assessment
20
2019
1339
1.320
 Why?
Electrocardiography
11
2016
279
1.310
 Why?
Hospital Mortality
17
2020
451
1.230
 Why?
Hemorrhage
14
2018
222
1.200
 Why?
Coronary Angiography
19
2020
384
1.170
 Why?
Myocardial Revascularization
9
2017
29
1.080
 Why?
Platelet Glycoprotein GPIIb-IIIa Complex
12
2012
46
1.070
 Why?
Drug-Eluting Stents
7
2020
101
1.070
 Why?
Coronary Disease
13
2007
164
1.050
 Why?
Hirudins
7
2016
24
1.050
 Why?
Coronary Restenosis
7
2020
39
1.030
 Why?
Aged
74
2021
10142
1.000
 Why?
Anticoagulants
12
2015
276
0.980
 Why?
Peptide Fragments
7
2016
207
0.970
 Why?
Thiophenes
8
2014
46
0.950
 Why?
Time Factors
29
2020
2970
0.910
 Why?
Middle Aged
74
2020
13028
0.910
 Why?
Piperazines
8
2014
125
0.900
 Why?
Treatment Outcome
50
2021
5456
0.870
 Why?
Peptides
8
2010
234
0.860
 Why?
Purinergic P2Y Receptor Antagonists
6
2016
35
0.820
 Why?
Cardiac Catheterization
12
2021
241
0.810
 Why?
Male
85
2021
26652
0.810
 Why?
Platelet Aggregation
9
2014
77
0.800
 Why?
Sirolimus
5
2013
72
0.800
 Why?
Postoperative Complications
8
2020
1071
0.790
 Why?
Coronary Vessels
6
2017
172
0.780
 Why?
Myocardial Ischemia
7
2010
132
0.770
 Why?
Humans
112
2021
52114
0.760
 Why?
Female
82
2021
28055
0.750
 Why?
Coronary Artery Bypass
10
2015
136
0.750
 Why?
Guideline Adherence
6
2015
141
0.740
 Why?
Risk Factors
29
2020
3922
0.720
 Why?
Practice Guidelines as Topic
10
2015
494
0.660
 Why?
Heart Transplantation
4
2015
341
0.650
 Why?
Fibrinolytic Agents
5
2020
131
0.650
 Why?
Thrombosis
6
2014
252
0.630
 Why?
United States
27
2021
5168
0.620
 Why?
Drug Substitution
3
2014
13
0.610
 Why?
Retrospective Studies
27
2020
6610
0.590
 Why?
Follow-Up Studies
17
2019
2282
0.570
 Why?
Aged, 80 and over
24
2021
3382
0.550
 Why?
Myocardial Reperfusion
3
2015
13
0.540
 Why?
Saphenous Vein
2
2015
65
0.520
 Why?
Angina, Unstable
7
2006
30
0.510
 Why?
Cardiovascular Agents
3
2020
65
0.500
 Why?
Heparin, Low-Molecular-Weight
2
2016
22
0.500
 Why?
Renal Insufficiency, Chronic
3
2013
201
0.470
 Why?
Tyrosine
3
2004
91
0.470
 Why?
Immunosuppressive Agents
5
2013
249
0.460
 Why?
Coronary Sinus
1
2015
5
0.450
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
4
2017
147
0.450
 Why?
Anastomosis, Surgical
1
2015
69
0.450
 Why?
Metals
2
2012
37
0.440
 Why?
Inpatients
3
2019
206
0.440
 Why?
Heart Valve Prosthesis
3
2021
88
0.440
 Why?
Prospective Studies
16
2021
2424
0.420
 Why?
Patient Admission
1
2014
80
0.420
 Why?
Heart Valve Prosthesis Implantation
3
2021
101
0.420
 Why?
Evidence-Based Medicine
7
2012
270
0.410
 Why?
Recombinant Proteins
8
2016
492
0.410
 Why?
Blood Platelets
6
2014
244
0.410
 Why?
Aspirin
7
2015
121
0.390
 Why?
Hemoglobins
1
2013
111
0.380
 Why?
Cardiology
3
2021
101
0.370
 Why?
Survival Rate
9
2017
945
0.370
 Why?
Severity of Illness Index
7
2018
1035
0.360
 Why?
Diabetes Mellitus, Type 1
1
2014
221
0.360
 Why?
Blood Vessel Prosthesis Implantation
2
2012
122
0.350
 Why?
Aorta
1
2012
170
0.350
 Why?
Mitral Valve
3
2020
56
0.350
 Why?
Aortic Aneurysm, Abdominal
1
2011
52
0.340
 Why?
Mitral Valve Annuloplasty
2
2021
6
0.340
 Why?
Diabetes Mellitus, Type 2
2
2014
562
0.330
 Why?
Mesenteric Artery, Superior
1
2010
10
0.320
 Why?
Ischemic Attack, Transient
2
2020
59
0.310
 Why?
Bioprosthesis
2
2021
41
0.310
 Why?
Angioplasty, Balloon
1
2010
70
0.310
 Why?
Thrombectomy
1
2010
73
0.300
 Why?
Stroke
4
2020
514
0.300
 Why?
Prosthesis Design
6
2021
260
0.300
 Why?
Kidney Diseases
1
2011
229
0.300
 Why?
Patient Discharge
5
2018
322
0.300
 Why?
Prosthesis Failure
2
2020
112
0.290
 Why?
Immunoglobulin Fab Fragments
3
2004
19
0.290
 Why?
Intracranial Hemorrhages
2
2019
41
0.290
 Why?
American Heart Association
2
2021
33
0.280
 Why?
Postoperative Hemorrhage
1
2008
54
0.280
 Why?
Chi-Square Distribution
6
2014
292
0.260
 Why?
Prognosis
9
2019
2093
0.260
 Why?
Odds Ratio
6
2014
564
0.260
 Why?
Stroke Volume
3
2019
159
0.250
 Why?
Antibodies, Monoclonal
4
2004
475
0.250
 Why?
Peripheral Arterial Disease
2
2019
77
0.240
 Why?
Cardiovascular Diseases
2
2021
493
0.240
 Why?
Internal Mammary-Coronary Artery Anastomosis
1
2005
6
0.230
 Why?
Mammary Arteries
1
2005
10
0.230
 Why?
Incidence
7
2019
1070
0.230
 Why?
Comorbidity
5
2015
628
0.230
 Why?
Ventricular Function, Left
2
2019
177
0.230
 Why?
Intermittent Claudication
3
2014
16
0.230
 Why?
Antithrombins
3
2016
22
0.220
 Why?
Heparin
1
2005
87
0.220
 Why?
Coronary Stenosis
1
2005
98
0.210
 Why?
Heart Valve Diseases
2
2020
55
0.210
 Why?
Platelet Function Tests
5
2014
22
0.200
 Why?
Logistic Models
7
2014
925
0.200
 Why?
Vascular Diseases
2
2015
74
0.200
 Why?
Administration, Oral
4
2013
453
0.200
 Why?
Shock, Cardiogenic
2
2018
34
0.200
 Why?
Aryl Hydrocarbon Hydroxylases
2
2013
76
0.200
 Why?
Double-Blind Method
7
2014
718
0.190
 Why?
Aortic Valve
2
2019
125
0.190
 Why?
Angiotensin Receptor Antagonists
2
2019
22
0.180
 Why?
Angiotensin-Converting Enzyme Inhibitors
2
2019
82
0.180
 Why?
Drug Therapy, Combination
5
2015
399
0.180
 Why?
Research Report
1
2021
19
0.180
 Why?
Receptors, Purinergic P2Y12
4
2013
17
0.170
 Why?
Recurrence
8
2018
680
0.170
 Why?
Ethics, Medical
1
2021
44
0.170
 Why?
Adrenergic beta-Antagonists
2
2018
111
0.170
 Why?
Patient Selection
7
2016
265
0.170
 Why?
Influenza, Human
1
2021
85
0.160
 Why?
Syndrome
6
2007
247
0.160
 Why?
Cardiac Catheters
1
2020
12
0.160
 Why?
Creatine Kinase
1
2000
32
0.160
 Why?
Hemostatic Techniques
3
2009
31
0.160
 Why?
Hospitalization
7
2016
739
0.160
 Why?
Angioplasty
1
2000
21
0.160
 Why?
Multivariate Analysis
7
2016
600
0.160
 Why?
Calcinosis
1
2020
52
0.160
 Why?
Renin-Angiotensin System
1
2019
58
0.150
 Why?
Cohort Studies
6
2018
1541
0.150
 Why?
Databases, Factual
4
2019
714
0.140
 Why?
Aortic Valve Stenosis
1
2019
78
0.140
 Why?
Cell Adhesion Molecules
3
2013
88
0.140
 Why?
Decision Support Techniques
1
2018
70
0.140
 Why?
Mitral Valve Insufficiency
1
2018
55
0.130
 Why?
Blood Coagulation
3
2014
60
0.130
 Why?
Neoplasms
2
2017
1288
0.130
 Why?
Adult
11
2015
14095
0.130
 Why?
Graft Occlusion, Vascular
2
2012
78
0.130
 Why?
Exercise Tolerance
2
2014
48
0.120
 Why?
Microfilament Proteins
2
2013
44
0.120
 Why?
Brachytherapy
3
2002
51
0.120
 Why?
Europe
4
2018
91
0.120
 Why?
Glomerular Filtration Rate
2
2013
127
0.120
 Why?
Radiography
4
2011
472
0.120
 Why?
Consensus
3
2021
190
0.120
 Why?
Research Design
2
2016
367
0.120
 Why?
Predictive Value of Tests
5
2018
939
0.120
 Why?
Phosphoproteins
2
2013
120
0.120
 Why?
Troponin
2
2012
16
0.120
 Why?
Creatine Kinase, MB Form
2
2012
10
0.120
 Why?
Heart Diseases
2
2012
220
0.110
 Why?
Vitamin K
1
2014
17
0.110
 Why?
Genotype
2
2014
563
0.110
 Why?
Holidays
1
2014
4
0.110
 Why?
Warfarin
1
2015
82
0.110
 Why?
Morbidity
1
2014
140
0.100
 Why?
Phenotype
2
2014
794
0.100
 Why?
Gene Transfer Techniques
2
2003
44
0.100
 Why?
Drug Prescriptions
1
2013
104
0.100
 Why?
Atrial Fibrillation
1
2015
200
0.100
 Why?
Statistics, Nonparametric
1
2013
196
0.100
 Why?
Aortography
1
2012
33
0.100
 Why?
Pharmacogenetics
1
2012
51
0.100
 Why?
Adenosine Monophosphate
1
2012
14
0.100
 Why?
Dose-Response Relationship, Drug
1
2016
1368
0.100
 Why?
Quinazolinones
1
2012
7
0.090
 Why?
Kidney Function Tests
1
2012
55
0.090
 Why?
Pyridines
1
2013
134
0.090
 Why?
Drug Delivery Systems
2
2005
146
0.090
 Why?
Chronic Disease
2
2011
585
0.090
 Why?
Femoral Artery
3
2009
107
0.090
 Why?
Propensity Score
3
2019
157
0.090
 Why?
Quality Indicators, Health Care
1
2012
91
0.090
 Why?
Bundle-Branch Block
1
2011
19
0.090
 Why?
Diabetes Complications
2
2002
124
0.090
 Why?
Emergency Service, Hospital
2
2013
515
0.090
 Why?
Aortic Rupture
1
2011
18
0.090
 Why?
Randomized Controlled Trials as Topic
5
2009
608
0.090
 Why?
Disease-Free Survival
5
2011
462
0.090
 Why?
Transportation of Patients
1
2011
39
0.090
 Why?
Sulfonamides
1
2012
132
0.090
 Why?
Hospitals
1
2012
180
0.090
 Why?
Diagnostic Imaging
1
2012
172
0.090
 Why?
Diabetic Angiopathies
1
2011
23
0.090
 Why?
Feasibility Studies
1
2012
399
0.080
 Why?
Prevalence
4
2019
1013
0.080
 Why?
Ischemia
1
2011
154
0.080
 Why?
Transplantation, Homologous
1
2011
149
0.080
 Why?
Algorithms
2
2008
663
0.080
 Why?
Patient Care Team
1
2012
271
0.080
 Why?
Graft Survival
1
2011
158
0.080
 Why?
Drug Administration Schedule
4
2014
374
0.080
 Why?
Health Services Accessibility
1
2014
438
0.080
 Why?
Fluoroscopy
1
2009
51
0.080
 Why?
Adolescent
3
2012
6681
0.080
 Why?
Clinical Trials as Topic
3
2008
463
0.080
 Why?
Genetic Vectors
2
2007
128
0.080
 Why?
Radiography, Interventional
1
2009
58
0.080
 Why?
Acute Disease
4
2014
386
0.080
 Why?
Endovascular Procedures
1
2011
179
0.080
 Why?
Preoperative Care
2
2012
174
0.070
 Why?
Thrombelastography
1
2009
27
0.070
 Why?
Palliative Care
1
2011
195
0.070
 Why?
Multicenter Studies as Topic
4
2017
112
0.070
 Why?
Emergency Treatment
1
2008
29
0.070
 Why?
Asia
2
2018
21
0.070
 Why?
Analysis of Variance
3
2009
554
0.070
 Why?
Age Factors
4
2018
1125
0.070
 Why?
Peripheral Vascular Diseases
1
2007
23
0.070
 Why?
Equipment Design
3
2020
290
0.070
 Why?
Plasmids
1
2007
164
0.060
 Why?
Kidney Failure, Chronic
1
2009
212
0.060
 Why?
International Cooperation
2
2016
52
0.060
 Why?
Thrombolytic Therapy
2
2004
113
0.060
 Why?
Young Adult
2
2012
4307
0.060
 Why?
Canada
2
2018
107
0.060
 Why?
Carrier Proteins
1
2007
316
0.060
 Why?
Coronary Vessel Anomalies
1
2005
37
0.060
 Why?
Iridium Radioisotopes
2
2002
5
0.060
 Why?
Quality of Health Care
1
2006
187
0.060
 Why?
Tennessee
1
2004
37
0.050
 Why?
Mississippi
1
2004
91
0.050
 Why?
Bradycardia
1
2004
38
0.050
 Why?
Infusions, Intravenous
1
2004
218
0.050
 Why?
Endothelial Growth Factors
1
2003
11
0.050
 Why?
Lymphokines
1
2003
20
0.050
 Why?
Oklahoma
2
2014
24
0.050
 Why?
Enoxaparin
1
2003
31
0.050
 Why?
Thrombocytopenia
1
2004
93
0.050
 Why?
Intercellular Signaling Peptides and Proteins
1
2003
106
0.050
 Why?
Neovascularization, Physiologic
1
2003
87
0.050
 Why?
Point-of-Care Systems
1
2003
65
0.050
 Why?
Coated Materials, Biocompatible
1
2002
34
0.050
 Why?
Paclitaxel
1
2002
90
0.050
 Why?
Platelet Activation
2
2013
46
0.050
 Why?
Thalidomide
1
2004
377
0.050
 Why?
Diabetes Mellitus
2
2002
316
0.050
 Why?
Tissue Adhesives
1
2001
15
0.050
 Why?
Latin America
1
2021
10
0.050
 Why?
Cell Cycle
1
2002
237
0.040
 Why?
Angioplasty, Laser
1
2001
1
0.040
 Why?
Heptanoic Acids
1
2000
35
0.040
 Why?
Anticholesteremic Agents
1
2000
31
0.040
 Why?
Punctures
3
2009
52
0.040
 Why?
Quality of Life
2
2007
878
0.040
 Why?
Pulmonary Edema
1
2000
15
0.040
 Why?
Walking
2
2014
106
0.040
 Why?
Pyrroles
1
2000
72
0.040
 Why?
Regression Analysis
2
2016
399
0.040
 Why?
Yttrium Radioisotopes
1
2000
9
0.040
 Why?
Atherectomy, Coronary
1
1999
6
0.040
 Why?
Arterial Occlusive Diseases
1
1999
82
0.040
 Why?
Vaccination
1
2021
296
0.040
 Why?
Cause of Death
1
2019
162
0.040
 Why?
Tissue Plasminogen Activator
1
1999
108
0.040
 Why?
Gender Identity
1
2018
26
0.040
 Why?
Length of Stay
1
2001
666
0.040
 Why?
Arkansas
1
2004
2016
0.040
 Why?
Brazil
1
2018
38
0.040
 Why?
Intra-Aortic Balloon Pumping
1
2018
7
0.040
 Why?
Echocardiography, Doppler, Color
1
2018
21
0.040
 Why?
Sweden
1
2018
11
0.040
 Why?
Hypolipidemic Agents
1
1998
30
0.040
 Why?
Erythrocyte Transfusion
1
2018
51
0.030
 Why?
Administration, Intravenous
1
2018
73
0.030
 Why?
Echocardiography, Transesophageal
1
2018
60
0.030
 Why?
South America
1
2017
4
0.030
 Why?
Cardiotonic Agents
1
2018
85
0.030
 Why?
North America
1
2017
75
0.030
 Why?
Recovery of Function
1
2018
201
0.030
 Why?
Methods
1
1996
53
0.030
 Why?
Equipment and Supplies
1
1996
16
0.030
 Why?
Hemodynamics
1
2018
264
0.030
 Why?
Internationality
1
2016
46
0.030
 Why?
Patient Readmission
1
2018
243
0.030
 Why?
Blood Transfusion
1
2016
129
0.030
 Why?
Intraoperative Complications
1
1996
113
0.030
 Why?
International Normalized Ratio
1
2014
29
0.030
 Why?
Ankle Brachial Index
1
2014
15
0.030
 Why?
Animals
4
2002
13332
0.030
 Why?
Mobility Limitation
1
2014
27
0.030
 Why?
Drug Resistance
1
2014
68
0.030
 Why?
Aryldialkylphosphatase
1
2013
5
0.030
 Why?
Blood Pressure
2
2007
535
0.030
 Why?
Sex Factors
2
2009
731
0.030
 Why?
Biotransformation
1
2013
86
0.030
 Why?
Exercise Test
1
2014
142
0.030
 Why?
Oxygen Consumption
1
2014
200
0.020
 Why?
Polymorphism, Genetic
1
2013
182
0.020
 Why?
Child
1
2005
7147
0.020
 Why?
Alleles
1
2013
277
0.020
 Why?
Adrenergic beta-1 Receptor Antagonists
1
2012
7
0.020
 Why?
Drug Antagonism
1
2012
8
0.020
 Why?
Embolic Protection Devices
1
2012
7
0.020
 Why?
Critical Pathways
1
2012
36
0.020
 Why?
Injections, Intravenous
1
2012
133
0.020
 Why?
Secondary Prevention
1
2012
84
0.020
 Why?
Natriuretic Peptide, Brain
1
2011
31
0.020
 Why?
Models, Statistical
1
2012
231
0.020
 Why?
Kaplan-Meier Estimate
1
2011
482
0.020
 Why?
Cross-Over Studies
1
2011
238
0.020
 Why?
Cells, Cultured
1
2013
1568
0.020
 Why?
Multiple Myeloma
1
2004
2999
0.020
 Why?
Femur Head
1
2009
26
0.020
 Why?
Probability
2
2001
171
0.020
 Why?
Confidence Intervals
1
2009
159
0.020
 Why?
Area Under Curve
1
2009
182
0.020
 Why?
Hemorheology
1
2009
6
0.020
 Why?
Receptors, Thrombin
1
2009
14
0.020
 Why?
Adenosine Diphosphate
1
2009
20
0.020
 Why?
Polysaccharides
1
2009
54
0.020
 Why?
Linear Models
1
2009
290
0.020
 Why?
Cross-Sectional Studies
1
2014
1665
0.020
 Why?
Patient Education as Topic
1
2011
318
0.020
 Why?
Collagen
1
2009
215
0.020
 Why?
Ankle
1
2007
15
0.020
 Why?
Brachial Artery
1
2007
17
0.020
 Why?
Injections, Intramuscular
1
2007
57
0.020
 Why?
Calcium-Binding Proteins
1
2007
57
0.020
 Why?
Disease Progression
1
2010
866
0.020
 Why?
Heart Conduction System
1
2006
25
0.020
 Why?
Combined Modality Therapy
2
1999
634
0.020
 Why?
Sex Distribution
1
2006
138
0.020
 Why?
Age Distribution
1
2006
174
0.020
 Why?
Body Mass Index
1
2009
699
0.020
 Why?
Genetic Therapy
1
2007
124
0.020
 Why?
Insurance, Health
1
2006
133
0.010
 Why?
Ultrasonography, Interventional
1
2006
137
0.010
 Why?
Societies, Medical
1
2005
200
0.010
 Why?
Platelet Adhesiveness
1
2004
14
0.010
 Why?
Abnormalities, Multiple
1
2005
168
0.010
 Why?
Platelet Count
1
2004
76
0.010
 Why?
Vascular Endothelial Growth Factors
1
2003
15
0.010
 Why?
Adenoviridae
1
2003
47
0.010
 Why?
Injections, Subcutaneous
1
2003
51
0.010
 Why?
Smoking
1
2006
516
0.010
 Why?
Endpoint Determination
1
2002
27
0.010
 Why?
Vascular Endothelial Growth Factor A
1
2003
187
0.010
 Why?
Echocardiography
1
2005
415
0.010
 Why?
Instillation, Drug
1
2002
2
0.010
 Why?
Catheters, Indwelling
1
2001
56
0.010
 Why?
Angina Pectoris
1
2001
20
0.010
 Why?
Survival Analysis
1
2002
667
0.010
 Why?
Hypoglycemic Agents
1
2002
217
0.010
 Why?
District of Columbia
1
2000
22
0.010
 Why?
Insulin
1
2002
484
0.010
 Why?
Tunica Intima
1
2000
56
0.010
 Why?
Partial Thromboplastin Time
1
1999
14
0.010
 Why?
Cineangiography
1
1999
10
0.010
 Why?
Prothrombin Time
1
1999
18
0.010
 Why?
United States Food and Drug Administration
1
1999
90
0.010
 Why?
Radiographic Image Enhancement
1
1999
30
0.010
 Why?
Coronary Thrombosis
1
1999
23
0.010
 Why?
Coronary Circulation
1
1999
57
0.010
 Why?
Regional Blood Flow
1
1999
110
0.010
 Why?
Dogs
1
1999
182
0.010
 Why?
Radiotherapy, Adjuvant
1
1999
63
0.010
 Why?
Safety
1
1999
80
0.010
 Why?
Swine
1
2000
426
0.010
 Why?
Sensitivity and Specificity
1
2000
871
0.010
 Why?
Postoperative Care
1
1998
102
0.010
 Why?
Lipids
1
1998
159
0.010
 Why?
Disease Models, Animal
1
1999
1467
0.010
 Why?
Mice
1
1999
5877
0.000
 Why?
Saucedo's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (377) concept(s)
_
Co-Authors Expand Description
See all (4) people
_
Similar People Expand Description
See all (27) people
_
Same Department Expand Description
Search Department